Zobrazeno 1 - 10 of 26 pro vyhledávání: '"A. Pelufo Pellicer"'
4
Estudio de utilización y descripción de costes de eritropoyetina en pacientes hematológicos
Autor: A. Pelufo Pellicer, E. Monte Boquet, J.L. Poveda Andrés, M.J. Cuéllar Monreal
Publikováno v: Farmacia Hospitalaria. 30:343-350
Objective: To assess the effectiveness of erythropoietin use in hematologic patients; to analyze the extent to which recommendations are applied as provided by Spanish prescribing information, American Society of Clinical Oncology (ASCO) and American
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e0ebe87249cd2217206d9085d44ea73
https://doi.org/10.1016/s1130-6343(06)74005-3
Zobrazit plný text záznamu
5
Leflunomida: valoración del riesgo teratógeno en el primer trimestre de embarazo
Autor: C. Casanova Sorní, A. Pelufo Pellicer, J.L. Poveda Andrés, E. Romá Sánchez
Publikováno v: Farmacia Hospitalaria. 29:265-268
Summary Objective: To assess the teratogenic risk associated with leflunomide during the first quarter of pregnancy, and to establish guidelines to minimize said risk. Method: Literature search using tertiary, secondary, and primary sources related t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::01ba5e78e73926d286be68b33baf5fd8
https://doi.org/10.1016/s1130-6343(05)73675-8
Zobrazit plný text záznamu
7
[A descriptive study of erythropoietin use and cost in hematologic patients]
Autor: A, Pelufo Pellicer, E, Monte Boquet, J L, Poveda Andrés, M J, Cuéllar Monreal
Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 30(6)
To assess the effectiveness of erythropoietin use in hematologic patients; to analyze the extent to which recommendations are applied as provided by Spanish prescribing information, American Society of Clinical Oncology (ASCO) and American Society of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a50fbba58189d93bee1966784838b3d6
https://pubmed.ncbi.nlm.nih.gov/17298191
Zobrazit plný text záznamu
8
Akademický článek
Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
Autor: Pelufo-Pellicer, Ana, a<%2Fce%3Asup>+Ángeles+López-Montenegro%22">Soria, M